These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30301189)

  • 21. Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.
    Xu Z; Yang Y; Li B; Li Y; Xia K; Yang Y; Li X; Wang M; Li S; Wu H
    Cell Death Dis; 2018 May; 9(5):559. PubMed ID: 29752474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
    Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
    Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
    Tang B; Jiang J
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.
    Sun H; Wang G; Peng Y; Zeng Y; Zhu QN; Li TL; Cai JQ; Zhou HH; Zhu YS
    Oncol Rep; 2015 Jun; 33(6):3045-52. PubMed ID: 25846769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel role for PINX1 as a coregulator of nuclear hormone receptors.
    Noriega-Reyes MY; Rivas-Torres MA; Oñate-Ocaña LF; Vallés AJ; Baranda-Avila N; Langley E
    Mol Cell Endocrinol; 2015 Oct; 414():9-18. PubMed ID: 26187699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines.
    Wang D; Huang P; Zhu B; Sun L; Huang Q; Wang J
    Mol Med Rep; 2012 Sep; 6(3):591-6. PubMed ID: 22711074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
    Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
    He RQ; Xiong DD; Ma J; Hu XH; Chen G; Sun WL
    Cell Physiol Biochem; 2018; 51(3):1027-1040. PubMed ID: 30476925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.
    Wang S; Luo H; Wang C; Sun H; Sun G; Sun N; Zeng K; Song H; Zou R; Zhou T; Cong R; Liu W; Yang L; Li D; Zhou X; Zhong X; Lin L; Jiao J; Yan G; Wang X; Min X; Cao L; Zhao Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1615-1628. PubMed ID: 28216286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.
    Xiang Y; Lu DL; Li JP; Yu CX; Zheng DL; Huang X; Wang ZY; Hu P; Liao XH; Zhang TC
    IUBMB Life; 2016 Jun; 68(6):477-87. PubMed ID: 27156566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
    Lopes R; Korkmaz G; Revilla SA; van Vliet R; Nagel R; Custers L; Kim Y; van Breugel PC; Zwart W; Moumbeini B; Manber Z; Elkon R; Agami R
    Cancer Lett; 2018 Nov; 436():87-95. PubMed ID: 30145202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells.
    Magne Nde CB; Casas Gimeno G; Docanto M; Knower KC; Young MJ; Buehn J; Sayed E; Clyne CD
    J Mol Biol; 2018 May; 430(10):1531-1543. PubMed ID: 29555554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of the CLOCK gene by E2-ERα signaling promotes the proliferation of breast cancer cells.
    Xiao L; Chang AK; Zang MX; Bi H; Li S; Wang M; Xing X; Wu H
    PLoS One; 2014; 9(5):e95878. PubMed ID: 24789043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells.
    Ansems M; Søndergaard JN; Sieuwerts AM; Looman MW; Smid M; de Graaf AM; de Weerd V; Zuidscherwoude M; Foekens JA; Martens JW; Adema GJ
    Breast Cancer Res Treat; 2015 Feb; 149(3):693-703. PubMed ID: 25663546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
    Lin CL; Tan X; Chen M; Kusi M; Hung CN; Chou CW; Hsu YT; Wang CM; Kirma N; Chen CL; Lin CH; Lathrop KI; Elledge R; Kaklamani VG; Mitsuya K; Huang TH
    BMC Med Genomics; 2020 May; 13(1):69. PubMed ID: 32408897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.